Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07173816 · ClinicalTrials.gov registry record · NA
Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and Sexual Health Choices
A NA study, sponsored by University of Georgia.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07173816: Clinical Trial NA study, sponsored by University of Georgia.
NCT07173816 is a NA study that has not yet begun recruiting, run by University of Georgia. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07173816, a NA study, has not yet begun recruiting, sponsored by University of Georgia.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Pilot testing of EMPOWER, a group sexual health intervention, to increase uptake and persistence of PrEP
Primary Outcome
Enrollment rate will be used an indicator of the feasibility of the intervention
Interventions
- BEHAVIORAL EMPOWER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What is known before NCT07173816 opens enrollment
NCT07173816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which EMPOWER is the first listed.
NCT07173816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07173816 about?
NCT07173816 is a clinical study titled "Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and Sexual Health Choices". Pilot testing of EMPOWER, a group sexual health intervention, to increase uptake and persistence of PrEP
What is the current status of trial NCT07173816?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-08-01. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT07173816?
The interventions under investigation include: EMPOWER (BEHAVIORAL).
Who is sponsoring clinical trial NCT07173816?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07173816's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI